<DOC>
	<DOCNO>NCT02782689</DOCNO>
	<brief_summary>The primary objective study demonstrate non-inferiority 2-layer compression system Kit Biflex速 regard 4-layer compression system PROFORE速 treatment venous leg ulcer term complete heal 16 week .</brief_summary>
	<brief_title>Clinical Study Assess Efficacy Safety New Compression System Management Venous Leg Ulcers</brief_title>
	<detailed_description>This trial multicentre , randomize , comparative , open label clinical study conduct vascular medicine centre France , 2 parallel group 100 patient . The study conduct patient suffer venous leg ulcer ( stage C6 CEAP classification chronic venous disorder ) . The patient randomise inclusion : receive either Kit Biflex速 reference device ( Profore速 ) maximum 16 week ( full healing ) . Investigator assessment plan every 4 week +/- 3 day , 16 week .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Inpatients outpatient . Agreeing wear multilayer compression system throughout study period . Presenting active venous leg ulcer : Duration 124 month ( whether new ulcer recurrent ulcer ) ; Surface area 250 cm2 ; Venous , superficial postthrombotic ulcer confirm Doppler ultrasonography ( date within six month ) . With ankle circumference 1825 cm allow lay compression system . Able follow study instruction . Having read information sheet date sign informed consent form . Covered health insurance system . Scheduled surgery ulcer 16 week follow inclusion . Clinical superinfect ulcer control oral antibiotic . Malignant ulcer . Ulcer surface totally cover dry fibrinous tissue cover black necrotic plaque 10 % surface . Deep Vein Thrombosis within last 3 month . Corticosteroids treatment ( equivalent 10 mg per day prednisolone ) ongoing plan study . Radiotherapy , chemotherapy immunosuppressive therapy ongoing plan study . Erysipelas lymphangitis . Lower extremity arterial disease microangiopathy ( Ankle Brachial Pressure Index &lt; 0.8 &gt; 1.3 ) . Uncontrolled noninsulin dependent diabetes ( HbA1c &gt; 8 % ) . Insulindependent diabetes . Confined bed . With uncontrolled severe progressive disease . With know suspected hypersensitivity component study device . Who participate previous clinical study within past 3 month . Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>